Family Med Medical News about SUNCT syndrome; methylprednisolone therapy

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Methylprednisolone therapy for short-term prevention of SUNCT syndrome
Cephalalgia, 08/11/09

Trauninger A et al. – Short–lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is characterized by severe and frequent daily pain attacks causing transient physical disability for the patients during the headache period. Currently there is no option for abortive treatment of the attacks, mainly due to the short–lived nature and frequency of the repeated headaches, while highly efficacious therapy is also unavailable for short–term prevention. The authors report rapidly suppressed headache attacks with orally administered methylprednisolone in eight headache periods of three patients with idiopathic, episodic SUNCT syndrome. The remission was maintained until the period was over in all cases. Although the mechanism of methylprednisolone action is unclear, it is probably based on the anti–inflammatory effects of the drug.

Exclusive Author Commentary
Zoltan Pfund, 08/11/09

Corticosteroid therapy is an easily available effective treatment in the rare SUNCT syndrome.

<< Previous
Proposals for new standardized general diagnostic criteria for...

Next >>
Could MTA be a novel medicine on the recurrence therapy for GCTB